PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1491
https://www.valueinhealthjournal.com/article/S1098-3015(11)03053-1/fulltext
Title :
PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03053-1&doi=10.1016/j.jval.2011.08.1491
First page :
A506
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
1442